Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doriano Fabbro

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Nature Chemical Biology|January 18, 2006
Allosteric inhibitors of Bcr-abl-dependent cell proliferationFrancisco J Adrián, Qiang Ding, Taebo Sim, et al.
British Journal of Pharmacology|December 10, 2015
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptorsStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
British Journal of Pharmacology|October 22, 2017
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: EnzymesStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
Immunology|February 6, 2020
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacologySimon D Harding, Elena Faccenda, Christopher Southan, et al.
Journal of Medicinal Chemistry|August 30, 2019
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR InhibitorChiara Borsari, Denise Rageot, Alix Dall'Asen, et al.
Chemistry & Biology|February 1, 2011
Specific CLK inhibitors from a novel chemotype for regulation of alternative splicingOleg Fedorov, Kilian Huber, Andreas Eisenreich, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationPascal Furet, Vito Guagnano, Robin A Fairhurst, et al.
British Journal of Pharmacology|December 10, 2015
The Concise Guide to PHARMACOLOGY 2015/16: EnzymesStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
The Biochemical Journal|June 21, 2003
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)Stefania Sarno, Erika de Moliner, Maria Ruzzene, et al.
British Journal of Pharmacology|October 22, 2017
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptorsStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Nature Chemical Biology|January 18, 2006
Allosteric inhibitors of Bcr-abl-dependent cell proliferationFrancisco J Adrián, Qiang Ding, Taebo Sim, et al.
British Journal of Pharmacology|December 10, 2015
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptorsStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
British Journal of Pharmacology|October 22, 2017
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: EnzymesStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
Immunology|February 6, 2020
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacologySimon D Harding, Elena Faccenda, Christopher Southan, et al.
Journal of Medicinal Chemistry|August 30, 2019
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR InhibitorChiara Borsari, Denise Rageot, Alix Dall'Asen, et al.
Chemistry & Biology|February 1, 2011
Specific CLK inhibitors from a novel chemotype for regulation of alternative splicingOleg Fedorov, Kilian Huber, Andreas Eisenreich, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationPascal Furet, Vito Guagnano, Robin A Fairhurst, et al.
British Journal of Pharmacology|December 10, 2015
The Concise Guide to PHARMACOLOGY 2015/16: EnzymesStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
The Biochemical Journal|June 21, 2003
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)Stefania Sarno, Erika de Moliner, Maria Ruzzene, et al.
British Journal of Pharmacology|October 22, 2017
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptorsStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
Pageof 13